Logo

American Heart Association

  60
  0


Final ID:

State of the Art: Preventing Atrial Fibrillation

  • Sanders, Prashanthan  ( University of Adelaide , Adelaide , South Australia , Australia )
  • Author Disclosures:
    Prashanthan Sanders: DO have relevant financial relationships ; Advisor:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Becton Dickenson:Active (exists now) ; Research Funding (PI or named investigator):Boston Scientific:Past (completed) ; Research Funding (PI or named investigator):Abbott:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Advisor:CathRx:Active (exists now) ; Advisor:Pacemate:Active (exists now) ; Advisor:Boston-Scientific:Active (exists now) ; Advisor:Abbott:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiometabolic and Lifestyle Interventions for AF  

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Dapagliflozin to Reduce Atrial Fibrillation Burden After Catheter Ablation for Atrial Fibrillation in Patients Without Diabetes or Heart Failure: The DARE-AF Randomized Clinical Trial

Zhao Zixu, Dong Jz, Ma Changsheng, Yang Zejun, Jiang Chao, Wang Yiping, Xu Hui, Xu Yang, Sang Caihua, Long Deyong, Du Xin

Discussant: DARE-AF

Yancy Clyde

More abstracts from these authors:
Modifiable risk factors for atrial fibrillation

Albert Christine, Sanders Prashanthan

No Second Breakfast: GLP-1 agonists for HFpEF, obesity and AF

Gulati Martha, Sanders Prashanthan

You have to be authorized to contact abstract author. Please, Login
Not Available